Patent ID: 8846972

Claim:
A synergistically active molecular conjugate comprising a salicylate and a fatty acid wherein the salicylate is selected from the group consisting of substituted or unsubstituted salicylic acid, aminosalicylic acid, diflunisal, and triflusal, and wherein the fatty acid is selected from the group consisting of all-cis-7,10,13-hexadecatrienoic acid, α-linolenic acid, stearidonic acid, eicosatrienoic acid, eicosatetraenoic acid, eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), tetracosapentaenoic acid, or tetracosahexaenoic acid; with the proviso that when the molecular conjugate comprises a fatty acid containing seven contiguous unsubstituted methylene units, the methylene units must be preceded by an adjacent carbonyl moiety, wherein the synergistic activity is derived from in vivo delivery of the salicylate and of the fatty acid to a target tissue or a target cell together.